Global research and current trends on nanotherapy in lung cancer research: a bibliometric analysis of 20 years

被引:2
作者
Singh, Pooja [1 ]
Semwal, Prabhakar [1 ,2 ]
Gargi, Baby [1 ]
Painuli, Sakshi [3 ]
Aschner, Michael [4 ]
Alsharif, Khalaf F. [5 ]
Khan, Haroon [6 ]
Bachheti, Rakesh Kumar [7 ,8 ,10 ]
Worku, Limenew Abate [9 ]
机构
[1] Graph Era, Dept Biotechnol, 566-6 Bell Rd, Dehra Dun 248002, Uttarakhand, India
[2] Graph Era Hill Univ, Res & Dev Cell, Dehra Dun 248002, Uttarakhand, India
[3] Uttarakhand Council Biotechnol UCB, Dehra Dun 248006, Uttarakhand, India
[4] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10463 USA
[5] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, POB 11099, Taif 21944, Saudi Arabia
[6] Abdul Wali Khan Univ Mardan, Dept Pharm, Nardan 23200, Pakistan
[7] Addis Ababa Sci & Technol Univ, Coll Nat & Appl Sci, Dept Ind Chem, POB 16417, Addis Ababa, Ethiopia
[8] Graph Era Hill Univ, Dept Allied Sci, Dehra Dun 248002, Uttarakhand, India
[9] Debre Tabor Univ, Coll Nat & Computat Sci, Dept Chem, Debre Tabor, Ethiopia
[10] Chandigarh Univ, Univ Ctr Res & Dev, Gharuan 140413, Punjab, India
关键词
Lung cancer research; Bibliometric analysis; Nanomaterials; Scopus database; GOLD NANOPARTICLES; DRUG-DELIVERY; GOOGLE-SCHOLAR; NANOTECHNOLOGY; DIAGNOSIS; TOXICITY; THERAPY; SCIENCE; BREAST; SCOPUS;
D O I
10.1007/s12672-024-01332-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundLung cancer ranks as one of the most rapidly growing malignancies. Which is characterized by its poor prognosis and a low survival rate due to late diagnosis and limited efficacy of conventional treatments. In recent years nanotechnology has emerged as a promising frontier in the management of lung cancer, presenting novel strategies to enhance drug administration, improve therapeutic efficiency, and mitigate side effects. This research comprehensively evaluates the current state and research trends concerning the application of nanomaterials in lung cancer through bibliometric analysis.Materials and methodsWe employed a systematic approach by retrieving studies from the Scopus database that focused on nanomaterials and lung cancer between 2003 and 2023. Subsequently, we carefully selected relevant articles based on predetermined inclusion criteria. The selected publications were then subjected to bibliometric and visual analysis using softwares such as VOSviewer and Biblioshiny.ResultsA total of 3523 studies that meet inclusion criteria were selected for bibliometric analysis. We observed a progressive increase in the number of annual publications from 2003 to 2023, indicating the growing interest in this field. According to our analysis, China is the primary contributor to publication output among the countries. The "Ministry of Education of the People's Republic of China" was the most influential institution. Among the authors, "Dr. Jack A. Roth" and "Dr. Huang Leaf" had the highest number of publications and cited publications, respectively. The "International Journal of Nanomedicine" was found to be the most prolific journal in this field. Additionally, "Biomaterials" emerged as the most cited journal. Through keyword analysis, we identified five main research themes and future research directions; nono-immunotherapy and green synthesis are the hot topics in this research field.ConclusionOur study summarized the key characteristics of publications in this field and identified the most influential countries, institutions, authors, journals, hot topics, and trends related to the application of nanomaterials in lung cancer. These findings contribute to the existing body of knowledge and serve as a foundation for future research endeavors in this area. More effective efforts are needed in this field to reduce the burden of lung cancer and help achieve the United Nation's Sustainable Development Goals.
引用
收藏
页数:18
相关论文
共 78 条
[1]   Nanotechnology development in surgical applications: recent trends and developments [J].
Abaszadeh, Farzad ;
Ashoub, Muhammad Hossein ;
Khajouie, Ghazal ;
Amiri, Mahnaz .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
[2]   Bibliometrics: tracking research impact by selecting the appropriate metrics [J].
Agarwal, Ashok ;
Durairajanayagam, Damayanthi ;
Tatagari, Sindhuja ;
Esteves, Sandro C. ;
Harlev, Avi ;
Henkel, Ralf ;
Roychoudhury, Shubhadeep ;
Homa, Sheryl ;
Garrido Puchalt, Nicolas ;
Ramasamy, Ranjith ;
Majzoub, Ahmad ;
Ly, Kim Dao ;
Tvrda, Eva ;
Assidi, Mourad ;
Kesari, Kavindra ;
Sharma, Reecha ;
Banihani, Saleem ;
Ko, Edmund ;
Abu-Elmagd, Muhammad ;
Gosalvez, Jaime ;
Bashiri, Asher .
ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (02) :296-309
[3]   Therapeutics discovery: From bench to first in-human trials [J].
Al-Hujaily, Ensaf M. ;
Khatlani, Tanvir ;
Alehaideb, Zeyad ;
Ali, Rizwan ;
Almuzaini, Bader ;
Alrfaei, Bahauddeen M. ;
Iqbal, Jahangir ;
Islam, Imadul ;
Malik, Shuja ;
Marwani, Bader A. ;
Massadeh, Salam ;
Nehdi, Atef ;
Alsomaie, Barrak ;
Debasi, Bader ;
Bushnak, Ibraheem ;
Noibi, Saeed ;
Hussain, Syed ;
Wajid, Wahid Abdul ;
Armand, Jean-Pierre ;
Gul, Sheraz ;
Oyarzabal, Julen ;
Rais, Rana ;
Bountra, Chas ;
Alaskar, Ahmed ;
Al Knawy, Bander ;
Boudjelal, Mohamed .
BIOMEDICAL REPORTS, 2018, 8 (03) :275-282
[4]   Global trends, gaps, and future agenda in medulloblastoma research: a bibliometric analysis [J].
Alcantara, Jerome H. ;
Ornos, Eric David B. ;
Tantengco, Ourlad Alzeus G. .
CHILDS NERVOUS SYSTEM, 2023, 39 (11) :3185-3194
[5]   Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases [J].
AlRyalat, Saif Aldeen S. ;
Malkawi, Lna W. ;
Momani, Shaher M. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (152)
[6]   Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges [J].
Babu, Anish ;
Templeton, Amanda K. ;
Munshi, Anupama ;
Ramesh, Rajagopal .
JOURNAL OF NANOMATERIALS, 2013, 2013
[7]   Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas [J].
Bakx, R ;
Emous, M ;
Legemate, DA ;
Zoetmulder, FAN ;
van Tienhoven, G ;
Bemelman, WA ;
van Lanschot, JJB .
EJSO, 2006, 32 (05) :520-526
[8]   Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors [J].
Beg, Muhammad S. ;
Brenner, Andrew J. ;
Sachdev, Jasgit ;
Borad, Mitesh ;
Kang, Yoon-Koo ;
Stoudemire, Jay ;
Smith, Susan ;
Bader, Andreas G. ;
Kim, Sinil ;
Hong, David S. .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :180-188
[9]   Bibliometric indicators: opportunities and limits [J].
Belter, Christopher W. .
JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION, 2015, 103 (04) :219-221
[10]   Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin [J].
Brown, Sarah D. ;
Nativo, Paola ;
Smith, Jo-Ann ;
Stirling, David ;
Edwards, Paul R. ;
Venugopal, Balaji ;
Flint, David J. ;
Plumb, Jane A. ;
Graham, Duncan ;
Wheate, Nial J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (13) :4678-4684